A carregar...
Everolimus in the management of metastatic renal cell carcinoma: an evidence-based review of its place in therapy
INTRODUCTION: Renal cell carcinoma (RCC) is the most common type of kidney cancer in adults, and its pathogenesis is strictly related to altered cellular response to hypoxia, in which mTOR signaling pathway is implicated. Everolimus, an mTOR serine/threonine kinase inhibitor, represents a therapeuti...
Na minha lista:
| Publicado no: | Core Evid |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5012611/ https://ncbi.nlm.nih.gov/pubmed/27621699 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CE.S98687 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|